Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May 21:2019:9165214.
doi: 10.1155/2019/9165214. eCollection 2019.

Mitochondrial Entry of Cytotoxic Proteases: A New Insight into the Granzyme B Cell Death Pathway

Affiliations
Review

Mitochondrial Entry of Cytotoxic Proteases: A New Insight into the Granzyme B Cell Death Pathway

Denis Martinvalet. Oxid Med Cell Longev. .

Abstract

The mitochondria represent an integration and amplification hub for various death pathways including that mediated by granzyme B (GB), a granule enzyme expressed by cytotoxic lymphocytes. GB activates the proapoptotic B cell CLL/lymphoma 2 (Bcl-2) family member BH3-interacting domain death agonist (BID) to switch on the intrinsic mitochondrial death pathway, leading to Bcl-2-associated X protein (Bax)/Bcl-2 homologous antagonist/killer- (Bak-) dependent mitochondrial outer membrane permeabilization (MOMP), the dissipation of mitochondrial transmembrane potential (ΔΨm), and the production of reactive oxygen species (ROS). GB can also induce mitochondrial damage in the absence of BID, Bax, and Bak, critical for MOMP, indicating that GB targets the mitochondria in other ways. Interestingly, granzyme A (GA), GB, and caspase 3 can all directly target the mitochondrial respiratory chain complex I for ROS-dependent cell death. Studies of ROS biogenesis have revealed that GB must enter the mitochondria for ROS production, making the mitochondrial entry of cytotoxic proteases (MECP) an unexpected critical step in the granzyme death pathway. MECP requires an intact ΔΨm and is mediated though Sam50 and Tim22 channels in a mtHSP70-dependent manner. Preventing MECP severely compromises GB cytotoxicity. In this review, we provide a brief overview of the canonical mitochondrial death pathway in order to put into perspective this new insight into the GB action on the mitochondria to trigger ROS-dependent cell death.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Granzymes and caspase 3 enter the mitochondria through the Sam50 channel. Upon recognition of the target cell, the effector cell vectorially degranulates the cytotoxic granule content into the immunological synapse from where perforin, a pore forming protein, triggers membrane repair, which results in the internalization and delivery of the granzymes into the target cell cytosol. In the target cell cytosol, granzymes initiate cell death by cleaving various substrates. Both granzymes and caspase 3 cross the outer and the inner mitochondrial membrane through the Sam50 and Tim22 channels, respectively. Once in the matrix, granzyme and caspase 3 disrupt the electron transport chain (ETC) complex I and trigger ROS mediation of cell death.

Similar articles

Cited by

References

    1. Bachmann M. F., Kündig T. M., Freer G., et al. Induction of protective cytotoxic T cells with viral proteins. European Journal of Immunology. 1994;24(9):2228–2236. doi: 10.1002/eji.1830240944. - DOI - PubMed
    1. Kagi D., Hengartner H. Different roles for rcytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Current Opinion in Immunology. 1996;8(4):472–477. doi: 10.1016/S0952-7915(96)80033-1. - DOI - PubMed
    1. Kägi D., Ledermann B., Bürki K., Hengartner H., Zinkernagel R. M. CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. European Journal of Immunology. 1994;24(12):3068–3072. doi: 10.1002/eji.1830241223. - DOI - PubMed
    1. van den Broek M. E., Kägi D., Ossendorp F., et al. Decreased tumor surveillance in perforin-deficient mice. Journal of Experimental Medicine. 1996;184(5):1781–1790. doi: 10.1084/jem.184.5.1781. - DOI - PMC - PubMed
    1. Senovilla L., Vitale I., Martins I., et al. An immunosurveillance mechanism controls cancer cell ploidy. Science. 2012;337(6102):1678–1684. doi: 10.1126/science.1224922. - DOI - PubMed